The increasing potency of immunosuppression (IS) agents resulted in significantly
decreased rates of steroid resistant rejection and rejection related graft loss in liver …

Organ transplantation as an option to overcome end-stage diseases is common in countries
with advanced healthcare systems and is increasingly provided in emerging and developing …

Non-alcoholic fatty liver disease (NAFLD) is currently the fastest growing indication to liver
transplantation (LT) in Western Countries, both for end stage liver disease and …

Since the implementation of the Model of End-stage Liver Disease score-based allocation
system, the number of transplant candidates with impaired renal function has increased. The …

Donor-derived cell-free DNA (dd-cfDNA) has been evaluated as a rejection marker in organ
transplantation. This study sought to assess the utility of dd-cfDNA to diagnose graft injury in …

While advances in immunosuppressive therapy have lowered the rate of acute rejection
following liver transplantation, the consequence has been an increase in morbidity and …

A growing literature has highlighted important differences in transplant-related outcomes
between men and women. In the United States there are fewer women than men on the liver …

The outcome of liver transplantation has markedly improved in the last 3 decades. Although
early post‐transplantation outcomes have improved over time, this is not true of the long …

Although currently moderate and high intensity concurrent physical exercise is prescribed in
populations with special needs due to its greater effect on physical condition and health …

Cardiovascular (CV) events represent major impediments to the long‐term survival of liver
transplantation (LT) patients. The aim of this study was to assess whether the Framingham …